{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:50:28Z","timestamp":1740135028580,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW112-CDC-C-114-000104"],"award-info":[{"award-number":["MOHW112-CDC-C-114-000104"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH110-0M22"],"award-info":[{"award-number":["KMUH110-0M22"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kaohsiung Medical University Research Center Grant","award":["KMU-TC108B07"],"award-info":[{"award-number":["KMU-TC108B07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although indicator condition (IC)-guided HIV testing (IC-HIVT) is effective at facilitating timely HIV diagnosis, research on IC categories and the related HIV risk in Taiwan is limited. To improve the adoption and spread of IC-HIVT in Taiwan, this study compared the IC categories of people living with HIV (PLWH) and non-HIV controls and investigated delays in the diagnosis of HIV infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This nationwide, retrospective, 1:10-matched case\u2013control study analyzed data from the Notifiable Diseases Surveillance System and National Health Insurance Research Database to evaluate 42 ICs for the 5-year period preceding a matched HIV diagnostic date from 2009 to 2015. The ICs were divided into category 1 ICs (AIDS-defining opportunistic illnesses [AOIs]), category 2 ICs (diseases associated with impaired immunity or malignancy but not AOIs), category 3 ICs (ICs associated with sexual behaviors), and category 4 ICs (mononucleosis or mononucleosis-like syndrome). Logistic regression was used to evaluate the HIV risk associated with each IC category (at the overall and annual levels) before the index date. Wilcoxon rank-sum test was performed to assess changes in diagnostic delays following an incident IC category by HIV transmission routes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fourteen thousand three hundred forty-seven PLWH were matched with 143,470 non-HIV controls. The prevalence results for all ICs and category 1\u20134 ICs were, respectively, 42.59%, 11.16%, 15.68%, 26.48%, and 0.97% among PLWH and 8.73%, 1.05%, 4.53%, 3.69%, and 0.02% among non-HIV controls (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Each IC category posed a significantly higher risk of HIV infection overall and annually. The median (interquartile range) potential delay in HIV diagnosis was 15 (7\u201344), 324.5 (36\u2013947), 234 (13\u2013976), and 74 (33\u2013476) days for category 1\u20134 ICs, respectively. Except for category 1 for men who have sex with men, these values remained stable across 2009\u20132015, regardless of the HIV transmission route.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Given the ongoing HIV diagnostic delay, IC-HIVT should be upgraded and adapted to each IC category to enhance early HIV diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-18499-6","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:01:49Z","timestamp":1712332909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhancing indicator condition\u2013guided HIV testing in Taiwan: a nationwide case\u2013control study from 2009 to 2015"],"prefix":"10.1186","volume":"24","author":[{"given":"Chun-Yuan","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Wen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"18499_CR1","unstructured":"Issue Brief: Status Neutral HIV Care and Service Delivery [https:\/\/www.cdc.gov\/hiv\/policies\/data\/status-neutral-issue-brief.html] (accessed on 2 Mar 2024)."},{"issue":"12","key":"18499_CR2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/09540121.2014.923811","volume":"26","author":"TJ Aderemi","year":"2014","unstructured":"Aderemi TJ, Mac-Seing M, Woreta SA, Mati KA. Predictors of voluntary HIV counselling and testing services utilization among people with disabilities in Addis Ababa, Ethiopia. AIDS Care. 2014;26(12):1461\u20136.","journal-title":"AIDS Care"},{"issue":"24","key":"18499_CR3","first-page":"663","volume":"64","author":"P Seth","year":"2015","unstructured":"Seth P, Wang G, Collins NT, Belcher L. Identifying new positives and linkage to HIV medical care\u201323 testing site types, United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(24):663\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Rr-14","key":"18499_CR4","first-page":"1","volume":"55","author":"BM Branson","year":"2006","unstructured":"Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(Rr-14):1\u201317. quiz CE11-14.","journal-title":"MMWR Recomm Rep."},{"issue":"7","key":"18499_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/hiv.12022","volume":"14","author":"JV Lazarus","year":"2013","unstructured":"Lazarus JV, Hoekstra M, Raben D, Delpech V, Coenen T, Lundgren JD. The case for indicator condition-guided HIV screening. HIV Med. 2013;14(7):445\u20138.","journal-title":"HIV Med"},{"issue":"2","key":"18499_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00126334-200302010-00005","volume":"32","author":"D Klein","year":"2003","unstructured":"Klein D, Hurley LB, Merrill D, Quesenberry CP Jr. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr. 2003;32(2):143\u201352.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"18499_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/aid.2015.0058","volume":"32","author":"SJ Jeong","year":"2016","unstructured":"Jeong SJ, Italiano C, Chaiwarith R, Ng OT, Vanar S, Jiamsakul A, et al. Late presentation into care of HIV disease and its associated factors in Asia: results of TAHOD. AIDS Res Hum Retroviruses. 2016;32:255\u201361.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"18499_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12981-021-00415-2","volume":"18","author":"C Sun","year":"2021","unstructured":"Sun C, Li J, Liu X, Zhang Z, Qiu T, Hu H, et al. HIV\/AIDS late presentation and its associated factors in China from 2010 to 2020: a systematic review and meta-analysis. AIDS Res Ther. 2021;18(1):96.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"18499_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s12889-018-5500-z","volume":"18","author":"CY Lee","year":"2018","unstructured":"Lee CY, Jen IA, Lan YC, Yen YF, Chuang PH, Chen M, et al. AIDS incidence trends at presentation and during follow-up among HIV-at-risk populations: a 15-year nationwide cohort study in Taiwan. BMC Public Health. 2018;18(1):589.","journal-title":"BMC Public Health"},{"issue":"9","key":"18499_CR10","doi-asserted-by":"publisher","first-page":"e1001510","DOI":"10.1371\/journal.pmed.1001510","volume":"10","author":"A Mocroft","year":"2013","unstructured":"Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9):e1001510.","journal-title":"PLoS Med"},{"issue":"5","key":"18499_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11904-022-00614-0","volume":"19","author":"QR Soh","year":"2022","unstructured":"Soh QR, Oh LYJ, Chow EPF, Johnson CC, Jamil MS, Ong JJ. HIV Testing uptake according to opt-in, opt-out or risk-based testing approaches: a systematic review and meta-analysis. Curr HIV\/AIDS Rep. 2022;19(5):375\u201383.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"9561","key":"18499_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(07)60249-9","volume":"369","author":"AR Lifson","year":"2007","unstructured":"Lifson AR, Rybicki SL. Routine opt-out HIV testing. Lancet. 2007;369(9561):539\u201340.","journal-title":"Lancet"},{"issue":"3 Suppl 2","key":"18499_CR13","doi-asserted-by":"publisher","first-page":"18734","DOI":"10.7448\/IAS.16.3.18734","volume":"16","author":"AL Stangl","year":"2013","unstructured":"Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(3 Suppl 2):18734.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"18499_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.aprim.2008.10.017","volume":"41","author":"L Garcia San Miguel","year":"2009","unstructured":"Garcia San Miguel L, Busto Martinez MJ, Bermudez Moreno E. Delay in the diagnosis of HIV infection in Spain: can we tackle this epidemic in primary care? Aten Primaria. 2009;41(4):215\u20137.","journal-title":"Aten Primaria."},{"issue":"1","key":"18499_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12879-017-2279-y","volume":"17","author":"IK Joore","year":"2017","unstructured":"Joore IK, Geerlings SE, Brinkman K, van Bergen JE, Prins JM. The importance of registration of sexual orientation and recognition of indicator conditions for an adequate HIV risk-assessment. BMC Infect Dis. 2017;17(1):178.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 2","key":"18499_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1468-1293.2008.00592.x","volume":"9","author":"B Gazzard","year":"2008","unstructured":"Gazzard B, Clumeck N, d\u2019Arminio Monforte A, Lundgren JD. Indicator disease-guided testing for HIV\u2013the next step for Europe? HIV Med. 2008;9(Suppl 2):34\u201340.","journal-title":"HIV Med"},{"issue":"Suppl 3","key":"18499_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hiv.12062","volume":"14","author":"D Raben","year":"2013","unstructured":"Raben D, Delpech V, de Wit J, Sullivan A, Lazarus JV, Dedes N, et al. Conclusions from the HIV in Europe Copenhagen 2012 Conference and ways forward: working together for optimal HIV testing and earlier care. HIV Med. 2013;14(Suppl 3):1\u20135.","journal-title":"HIV Med"},{"key":"18499_CR18","unstructured":"Guidance for implementing HIV testing in Adults in Health Care Settings. Copenhagen: HIV in Europe [http:\/\/hiveurope.eu\/Portals\/0\/Guidance.pdf.pdf.] (accessed on 2 Mar 2024)."},{"issue":"1","key":"18499_CR19","doi-asserted-by":"publisher","first-page":"e52845","DOI":"10.1371\/journal.pone.0052845","volume":"8","author":"AK Sullivan","year":"2013","unstructured":"Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS ONE. 2013;8(1):e52845.","journal-title":"PLoS ONE"},{"key":"18499_CR20","doi-asserted-by":"publisher","first-page":"100515","DOI":"10.1016\/j.lanepe.2022.100515","volume":"23","author":"SJ Bogers","year":"2022","unstructured":"Bogers SJ, Schim van der Loeff MF, Boyd A, Davidovich U, van der Valk M, Brinkman K, et al. Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2\u00b70): a multicenter, interrupted time-series analysis. Lancet Reg Health Eur. 2022;23:100515.","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"18499_CR21","doi-asserted-by":"publisher","first-page":"e0220108","DOI":"10.1371\/journal.pone.0220108","volume":"14","author":"D Raben","year":"2019","unstructured":"Raben D, Sullivan AK, Mocroft A, Kutsyna G, Had\u017eiosmanovi\u0107 V, Vassilenko A, et al. Improving the evidence for indicator condition guided HIV testing in Europe: results from the HIDES II study - 2012\u20132015. PLoS ONE. 2019;14(8):e0220108.","journal-title":"PLoS ONE"},{"issue":"3","key":"18499_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/imj.14418","volume":"50","author":"K King","year":"2020","unstructured":"King K, Seah J, Cheng A, Whiting S, Hoy J. Missed opportunities for HIV testing persist despite a single educational intervention: how can we close this evidence-practice gap? Intern Med J. 2020;50(3):285\u201392.","journal-title":"Intern Med J"},{"issue":"10","key":"18499_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10552-020-01333-w","volume":"31","author":"JK McGee-Avila","year":"2020","unstructured":"McGee-Avila JK, Doose M, Nova J, Kumar R, Stroup AM, Tsui J. Patterns of HIV testing among women diagnosed with invasive cervical cancer in the New Jersey Medicaid Program. Cancer Causes Control. 2020;31(10):931\u201341.","journal-title":"Cancer Causes Control"},{"issue":"6","key":"18499_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/ijgc-2019-000909","volume":"30","author":"J Alldredge","year":"2020","unstructured":"Alldredge J, Leaf MC, Patel P, Coakley K, Longoria T, McLaren C, et al. Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study. Int J Gynecol Cancer. 2020;30(6):772\u20136.","journal-title":"Int J Gynecol Cancer"},{"issue":"48","key":"18499_CR25","doi-asserted-by":"publisher","first-page":"2200338","DOI":"10.2807\/1560-7917.ES.2022.27.48.2200338","volume":"27","author":"CCE Jordans","year":"2022","unstructured":"Jordans CCE, Vasylyev M, Rae C, Jakobsen ML, Vassilenko A, Dauby N, et al. National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review. Euro Surveill. 2022;27(48):2200338.","journal-title":"Euro Surveill"},{"issue":"4","key":"18499_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/sextrans-2018-053792","volume":"95","author":"L Cayuelas Redondo","year":"2019","unstructured":"Cayuelas Redondo L, Ru\u00edz M, Kostov B, Sequeira E, Noguera P, Herrero MA, et al. Indicator condition-guided HIV testing with an electronic prompt in primary healthcare: a before and after evaluation of an intervention. Sex Transm Infect. 2019;95(4):238\u201343.","journal-title":"Sex Transm Infect"},{"issue":"11","key":"18499_CR27","doi-asserted-by":"publisher","first-page":"e0140845","DOI":"10.1371\/journal.pone.0140845","volume":"10","author":"D Raben","year":"2015","unstructured":"Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, et al. Auditing HIV testing rates across Europe: results from the HIDES 2 study. PLoS ONE. 2015;10(11):e0140845.","journal-title":"PLoS ONE"},{"issue":"4","key":"18499_CR28","first-page":"1014","volume":"13","author":"D Barbanotti","year":"2023","unstructured":"Barbanotti D, Tincati C, Tavelli A, Santoro A, Sala M, Bini T, et al. HIV-indicator condition guided testing in a hospital setting. Life (Basel). 2023;13(4):1014.","journal-title":"Life (Basel)"},{"key":"18499_CR29","unstructured":"Centers for Disease Control Annual Report [http:\/\/www.cdc.gov.tw\/infectionreport.aspx?nowtreeid=61AB37D12031B95A&treeid=075874DC882A5BFD] (accessed on 2 Mar 2024)."},{"issue":"2","key":"18499_CR30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jfma.2021.05.030","volume":"121","author":"SB Wu","year":"2022","unstructured":"Wu SB, Huang YC, Huang YF, Huang JC. Estimating HIV incidence, prevalence, and percent of undiagnosed infections in Taiwan using CD4 data. J Formos Med Assoc. 2022;121(2):482\u20139.","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"18499_CR31","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s40121-022-00619-7","volume":"11","author":"CY Lee","year":"2022","unstructured":"Lee CY, Lin YP, Wang SF, Lu PL. Late cART initiation consistently driven by late HIV presentation: a multicenter retrospective cohort study in Taiwan from 2009 to 2019. Infect Dis Ther. 2022;11(3):1033\u201356.","journal-title":"Infect Dis Ther"},{"key":"18499_CR32","unstructured":"1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults [https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00018871.htm] (accessed on 2 Mar 2024)."},{"issue":"3","key":"18499_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","volume":"22","author":"TM Cheng","year":"2003","unstructured":"Cheng TM. Taiwan\u2019s new national health insurance program: genesis and experience so far. Health Aff (Millwood). 2003;22(3):61\u201376.","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"18499_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/oxfordjournals.aje.a009786","volume":"149","author":"S Hennessy","year":"1999","unstructured":"Hennessy S, Bilker WB, Berlin JA, Strom BL. Factors influencing the optimal control-to-case ratio in matched case-control studies. Am J Epidemiol. 1999;149(2):195\u20137.","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"18499_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/pds.3263","volume":"21","author":"JA Rassen","year":"2012","unstructured":"Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 2):69\u201380.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"18499_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12875-016-0556-2","volume":"17","author":"IK Joore","year":"2016","unstructured":"Joore IK, Twisk DE, Vanrolleghem AM, de Ridder M, Geerlings SE, van Bergen JE, et al. The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care. BMC Fam Pract. 2016;17(1):161.","journal-title":"BMC Fam Pract"},{"issue":"12","key":"18499_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.annepidem.2018.03.011","volume":"28","author":"YF Yen","year":"2018","unstructured":"Yen YF, Jen IA, Chuang PH, Chen M, Lan YC, Lee CY, et al. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV\/AIDS. Ann Epidemiol. 2018;28(12):886-92.e883.","journal-title":"Ann Epidemiol"},{"key":"18499_CR38","unstructured":"European AIDS Clinical Society Guidelines v12.0 [https:\/\/www.eacsociety.org\/media\/guidelines-12.0.pdf] (accessed on 2 Mar 2024)."},{"issue":"1","key":"18499_CR39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/22221751.2022.2031309","volume":"11","author":"CS Tsai","year":"2022","unstructured":"Tsai CS, Lin KY, Liou BH, Chiou CS, Lin YC, Lee YT, et al. Changing epidemiology of shigellosis in Taiwan, 2010\u20132019: an emerging threat to HIV-infected patients and men who have sex with men. Emerg Microbes Infect. 2022;11(1):498\u2013506.","journal-title":"Emerg Microbes Infect"},{"key":"18499_CR40","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2018062","volume":"40","author":"LY Lin","year":"2018","unstructured":"Lin LY, Warren-Gash C, Smeeth L, Chen PC. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health. 2018;40: e2018062.","journal-title":"Epidemiol Health"},{"key":"18499_CR41","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"Organization GWH","year":"2016","unstructured":"Organization GWH. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed. 2016.","edition":"2nd ed"},{"key":"18499_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fpubh.2018.00057","volume":"6","author":"CL Kuo","year":"2018","unstructured":"Kuo CL, Duan Y, Grady J. Unconditional or conditional logistic regression model for age-matched case-control data? Front Public Health. 2018;6:57.","journal-title":"Front Public Health"},{"key":"18499_CR43","unstructured":"European Centre for Disease Prevention and Control. HIV testing in Europe. Evaluation of the impact of the ECDC guidance on HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: ECDC; 2016."},{"key":"18499_CR44","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.eclinm.2021.100877","volume":"35","author":"SJ Bogers","year":"2021","unstructured":"Bogers SJ, Hulstein SH, Schim van der Loeff MF, de Bree GJ, Reiss P, van Bergen J, et al. Current evidence on the adoption of indicator condition guided testing for HIV in western countries: a systematic review and meta-analysis. EClinicalMedicine. 2021;35:100877.","journal-title":"EClinicalMedicine."},{"issue":"1","key":"18499_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4997\/JRCPE.2011.103","volume":"41","author":"I Page","year":"2011","unstructured":"Page I, Phillips M, Flegg P, Palmer R. The impact of new national HIV testing guidelines at a district general hospital in an area of high HIV seroprevalence. J R Coll Physicians Edinb. 2011;41(1):9\u201312.","journal-title":"J R Coll Physicians Edinb"},{"issue":"4","key":"18499_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/hiv.12430","volume":"18","author":"E Lord","year":"2017","unstructured":"Lord E, Stockdale A, Malek R, Rae C, Sperle I, Raben D, et al. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions. HIV Med. 2017;18(4):300\u20134.","journal-title":"HIV Med"},{"issue":"10","key":"18499_CR47","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1080\/09540121.2016.1178700","volume":"28","author":"A Gull\u00f3n","year":"2016","unstructured":"Gull\u00f3n A, Verdejo J, de Miguel R, G\u00f3mez A, Sanz J. Factors associated with late diagnosis of HIV infection and missed opportunities for earlier testing. AIDS Care. 2016;28(10):1296\u2013300.","journal-title":"AIDS Care"},{"issue":"13","key":"18499_CR48","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1177\/0956462418781681","volume":"29","author":"E Youssef","year":"2018","unstructured":"Youssef E, Sanghera T, Bexley A, Hayes M, Perry N, Dosekun O, et al. HIV testing in patients presenting with indicator conditions in outpatient settings: offer and uptake rates, and educational and active interventions. Int J STD AIDS. 2018;29(13):1289\u201394.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"18499_CR49","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s40121-021-00494-8","volume":"10","author":"CY Lee","year":"2021","unstructured":"Lee CY, Wu PH, Lu PL, Liang FW. Different trends of distinct time points of AIDS events following HIV diagnosis in various at-risk populations: a retrospective nationwide cohort study in Taiwan. Infect Dis Ther. 2021;10(3):1715\u201332.","journal-title":"Infect Dis Ther"},{"issue":"2","key":"18499_CR50","doi-asserted-by":"publisher","first-page":"e0280877","DOI":"10.1371\/journal.pone.0280877","volume":"18","author":"S Popping","year":"2023","unstructured":"Popping S, Versteegh L, Nichols BE, van de Vijver D, van Sighem A, Reiss P, et al. Characteristics and short- and long-term direct medical costs among adults with timely and delayed presentation for HIV care in the Netherlands. PLoS ONE. 2023;18(2):e0280877.","journal-title":"PLoS ONE"},{"issue":"1","key":"18499_CR51","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12879-018-3251-1","volume":"18","author":"CY Lee","year":"2018","unstructured":"Lee CY, Tseng YT, Lin WR, Chen YH, Tsai JJ, Wang WH, et al. AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan. BMC Infect Dis. 2018;18(1):352.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"18499_CR52","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1080\/09540121.2021.1876837","volume":"33","author":"K Akinosoglou","year":"2021","unstructured":"Akinosoglou K, Kostaki EG, Paraskevis D, Gogos CA. Assessment of HIV testing recommendations in Greek specialty guidelines: a missed opportunity and room for improvement for recommending testing. AIDS Care. 2021;33(10):1312\u20135.","journal-title":"AIDS Care"},{"issue":"SUPPL 3","key":"18499_CR53","first-page":"14","volume":"22","author":"CC Jordans","year":"2021","unstructured":"Jordans CC, Rae C, Jacobsen ML, Akinosoglou K, Arends J, Dauby N, et al. A European review of HIV testing recommendations in national specialty guidelines for the management of HIV indicator conditions. HIV Med. 2021;22(SUPPL 3):14\u20135.","journal-title":"HIV Med"},{"issue":"5","key":"18499_CR54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jfma.2015.08.012","volume":"115","author":"SW Lai","year":"2016","unstructured":"Lai SW, Lin CL, Liao KF, Chen WC. Herpes zoster could be an early manifestation of undiagnosed human immunodeficiency virus infection. J Formos Med Assoc. 2016;115(5):372\u20136.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"18499_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0733-8635(18)30122-0","volume":"13","author":"MR Buchness","year":"1995","unstructured":"Buchness MR. Treatment of skin diseases in HIV-infected patients. Dermatol Clin. 1995;13(1):231\u20138.","journal-title":"Dermatol Clin"},{"issue":"Pt 1","key":"18499_CR56","first-page":"211","volume":"390","author":"SK Dunmire","year":"2015","unstructured":"Dunmire SK, Hogquist KA, Balfour HH. Infectious mononucleosis. Curr Top Microbiol Immunol. 2015;390(Pt 1):211\u201340.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"18499_CR57","doi-asserted-by":"publisher","first-page":"e012722","DOI":"10.1136\/bmjgh-2023-012722","volume":"8","author":"JY Choi","year":"2023","unstructured":"Choi JY, Poonkasetwattana M, Phanuphak N. Overcoming challenges across the HIV care continuum in the Asia-Pacific region: expert recommendations. BMJ Glob Health. 2023;8(7):e012722.","journal-title":"BMJ Glob Health"},{"issue":"611","key":"18499_CR58","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.3399\/bjgp13X668159","volume":"63","author":"S Damery","year":"2013","unstructured":"Damery S, Nichols L, Holder R, Ryan R, Wilson S, Warmington S, et al. Assessing the predictive value of HIV indicator conditions in general practice: a case-control study using the THIN database. Br J Gen Pract. 2013;63(611):e370\u20137.","journal-title":"Br J Gen Pract"},{"key":"18499_CR59","unstructured":"Taiwan Centers for Disease Control. Tuberculosis [https:\/\/www.cdc.gov.tw\/En\/Category\/ListContent\/bg0g_VU_Ysrgkes_KRUDgQ?uaid=0WialNbsh7SEGERJLa29FA] (accessed on 2 Mar 2024)."},{"issue":"2","key":"18499_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/jcm8020163","volume":"8","author":"CY Lee","year":"2019","unstructured":"Lee CY, Wu PH, Lu PL, Tsai HC. Changing spectrum of opportunistic illnesses among HIV-infected Taiwanese patients in response to a 10-year national anti-TB programme. J Clin Med. 2019;8(2):163.","journal-title":"J Clin Med"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18499-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-18499-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18499-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T17:02:23Z","timestamp":1712336543000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-18499-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["18499"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-18499-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Kaohsiung Medical University Hospital (KMUHIRB-E(II)-20200084 and KMUHIRB-SV(I)-20220078). The need for Informed Consent was waived by the Institutional Review Board of Kaohsiung Medical University Hospital due to the retrospective nature of the study. The study was carried out according to the principles expressed in the Declaration of Helsinki of 1964 and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"967"}}